DSGN logo

Design Therapeutics (DSGN) Cash From Operations

Annual CFO

-$58.56 M
-$7.24 M-14.11%

December 31, 2023


Summary


Performance

DSGN Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherDSGNcash flowmetrics:

Quarterly CFO

-$9.55 M
+$1.71 M+15.22%

September 30, 2024


Summary


Performance

DSGN Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherDSGNcash flowmetrics:

TTM CFO

-$46.04 M
+$4.99 M+9.77%

September 30, 2024


Summary


Performance

DSGN TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherDSGNcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

DSGN Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-14.1%0.0%0.0%
3 y3 years-575.5%0.0%0.0%
5 y5 years-10000.0%0.0%0.0%

DSGN Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-99.3%at low-3.5%+45.2%-56.7%+24.3%
5 y5-year<-9999.0%at low-630.4%+45.2%-1631.6%+24.3%
alltimeall time<-9999.0%at low-630.4%+45.2%-1631.6%+24.3%

Design Therapeutics Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$9.55 M(-15.2%)
-$46.04 M(-9.8%)
Jun 2024
-
-$11.26 M(-9.5%)
-$51.03 M(-4.7%)
Mar 2024
-
-$12.44 M(-2.8%)
-$53.58 M(-8.5%)
Dec 2023
-$58.56 M(+14.1%)
-$12.80 M(-11.9%)
-$58.56 M(-3.8%)
Sep 2023
-
-$14.53 M(+5.3%)
-$60.85 M(+1.1%)
Jun 2023
-
-$13.80 M(-20.8%)
-$60.22 M(+5.8%)
Mar 2023
-
-$17.42 M(+15.5%)
-$56.91 M(+10.9%)
Dec 2022
-$51.32 M
-$15.09 M(+8.6%)
-$51.32 M(+12.9%)
Sep 2022
-
-$13.90 M(+32.4%)
-$45.45 M(+14.4%)
Jun 2022
-
-$10.50 M(-11.2%)
-$39.72 M(+5.9%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$11.83 M(+28.2%)
-$37.51 M(+27.7%)
Dec 2021
-$29.38 M(+238.9%)
-$9.23 M(+13.0%)
-$29.38 M(+27.8%)
Sep 2021
-
-$8.16 M(-1.5%)
-$22.99 M(+37.8%)
Jun 2021
-
-$8.29 M(+124.2%)
-$16.69 M(+71.9%)
Mar 2021
-
-$3.70 M(+30.0%)
-$9.71 M(+12.0%)
Dec 2020
-$8.67 M(+6136.7%)
-$2.84 M(+53.0%)
-$8.67 M(+48.8%)
Sep 2020
-
-$1.86 M(+42.2%)
-$5.83 M(+46.9%)
Jun 2020
-
-$1.31 M(-50.8%)
-$3.97 M(+49.2%)
Mar 2020
-
-$2.66 M
-$2.66 M
Dec 2019
-$139.00 K
-
-

FAQ

  • What is Design Therapeutics annual cash flow from operations?
  • What is the all time high annual CFO for Design Therapeutics?
  • What is Design Therapeutics annual CFO year-on-year change?
  • What is Design Therapeutics quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Design Therapeutics?
  • What is Design Therapeutics quarterly CFO year-on-year change?
  • What is Design Therapeutics TTM cash flow from operations?
  • What is the all time high TTM CFO for Design Therapeutics?
  • What is Design Therapeutics TTM CFO year-on-year change?

What is Design Therapeutics annual cash flow from operations?

The current annual CFO of DSGN is -$58.56 M

What is the all time high annual CFO for Design Therapeutics?

Design Therapeutics all-time high annual cash flow from operations is -$139.00 K

What is Design Therapeutics annual CFO year-on-year change?

Over the past year, DSGN annual cash flow from operations has changed by -$7.24 M (-14.11%)

What is Design Therapeutics quarterly cash flow from operations?

The current quarterly CFO of DSGN is -$9.55 M

What is the all time high quarterly CFO for Design Therapeutics?

Design Therapeutics all-time high quarterly cash flow from operations is -$1.31 M

What is Design Therapeutics quarterly CFO year-on-year change?

Over the past year, DSGN quarterly cash flow from operations has changed by $0.00 (0.00%)

What is Design Therapeutics TTM cash flow from operations?

The current TTM CFO of DSGN is -$46.04 M

What is the all time high TTM CFO for Design Therapeutics?

Design Therapeutics all-time high TTM cash flow from operations is -$2.66 M

What is Design Therapeutics TTM CFO year-on-year change?

Over the past year, DSGN TTM cash flow from operations has changed by $0.00 (0.00%)